Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor

Journal of the American Society of Nephrology

Volumn 15, Issue 6, 2004, Pages 1452-1465

  Zhang, Shao Ling ^a   Moini, Babak ^a   Ingelfinger, Julie R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; DIPHENYLIODONIUM SALT; GENISTEIN; JANUS KINASE 2; LOSARTAN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN; STAT PROTEIN; TRANSCRIPTION FACTOR PAX2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INTERACTION; IMMUNOFLUORESCENCE; KIDNEY CELL; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; ONCOGENE RAS; PAX 2 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; UPREGULATION; WESTERN BLOTTING;

EID: 2542495011     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000130567.76794.58     Document Type: Article

References (67)

1. Bates CM: Kidney development: Regulatory molecules crucial to both mice and men. Mol Genet Metab 71: 391-396, 2000
2. Sigmund CD: Genetic manipulation of the renin-angiotensin system in the kidney. Acta Physiol Scand 173: 67-73, 2001
3. Johnston CI, Fabris B, Jandeleit K: Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Kidney Int 44[Suppl 42]: 559-563, 1993
4. Dzau VJ, Ingelfinger JR: Molecular biology and pathophysiology of the intrarenal renin-angiotensin system. J Hypertens 7[Suppl 7]: 53-58, 1989
5. Richou JP, Cordonnier JL, Bouhnik J, Clauser E, Corvol P, Menard P, Grignon G: Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res 122: 439-451, 1983
6. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen mRNA in the rat proximal tubule. A hypothesis for the intrarenal renin-angiotensin system. J Clin Invest 85: 417-423, 1990
7. Woods LL, Rasch R: Perinatal ANGII programs adult blood pressure, glomerular number, and renal function in rats. Am J Physiol 275: R1593-R1599, 1998
8. Woods LL, Ingelfinger JR, Nyengard J, Rasch R: Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49: 460-467, 2001
9. Pryde PG, Sedman AB, Nugent CE, Barr M Jr: Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3: 1575-1582, 1993
10. Matsusaka T, Miyazaki Y, Ichikawa I: The renin angiotensin system and kidney development. Annu Rev Physiol 64: 551-561, 2002
11. Torban E, Eccles MR, Favor J, Goodyer PR: PAX2 suppresses apoptosis in renal collecting duct cells. Am J Pathol 157: 833-842, 2000
12. Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE: Expression of the Pax2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ 3: 279-289, 1992
13. Torres M, Gomez-Pardo E, Dressler G, Gruss P: Pax2 controls multiple steps of urogenital development. Development 121: 4057-4065, 1995
14. Sanyanusin P, Schimmenti LA, McNoe LA, Ward TA, Pierpont MEM, Sullivan MJ, Dobyns WB, Eccles MR: Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteric reflux. Nat Genet 9: 358-364, 1995
15. Porteous S, Torban E, Cho N-P, Cunliffe HE, Chua L, McNoe LA, Ward TA, Souza C, Gus P, Giugliani R, Sato T, Yun K, Favor J, Sicotte M, Goodyer PR, Eccles MR: Primary renal hypoplasia in humans and mice with PAX2 mutations: Evidence of increased apoptosis in fetal kidneys of PAX1Neu +/- mutant mice. Hum Mol Genet 9: 1-9, 2000
16. Favor J, Sandulache R, Neuhauser-Klaus A, Pretsch W, Chatterjee B, Senft E, Wurst W, Blanquet V, Grimes P, Sporle R, Schughart K: The mouse PAX1Neu mutation is identical to a human PAX 2 mutation in a family with renal-coloboma syndrome and results in developmental defects of brain, ear, eye and kidney. Proc Natl Acad Sci U S A 89: 1179-1183, 1996
17. Chi N, Epstein JA: Getting your Pax straight: Pax proteins in development and disease. Trends Genet 18: 41-47, 2002
18. Maeshima A, Maeshima K, Nojima Y, Kojima I.: Involvement of Pax-2 in the action of activin a on tubular cell regeneration. J Am Soc Nephrol 13: 2850-2859, 2002
19. Bouchard M, Souabni A, Mandler M, Neubüser A, Busslinger M: Nephric lineage specification by Pax-2 and Pax8. Genes Dev 16: 2958-2970, 2002
20. Samuels HH, Standby F, Shapiro LE: Control of growth hormone synthesis in cultured GH1 cells by 3,5,3′-triiodo-L-thyronine and glucocorticoid agonists and antagonists: Studies on the independent and synergistic region of the growth hormone response. Biochemistry 18: 715-721, 1979
21. Valerius MT, Patterson LT, Witte DP, Potter SS: Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation. Mech Dev 112: 219-232, 2002
22. Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD, Ogden CW: Expression of the developmental and oncogenic PAX-2 gene in human prostate cancer. J Urol 165[Suppl]: 2115-2120, 2001
23. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D: The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucleic Acids Res 11: 1759-1771, 1983
24. Lechner MS, Levitan I, Dressler GR: PTIP, a novel BRCT domain-containing protein interacts with Pax-2 and is associated with active chromatin. Nucleic Acids Res 28: 2741-2751, 2000
25. Dressler GR, Douglass EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A 89: 1179-1183, 1992
26. Dressler Gr, Woolf AS: Pax-2 in development and renal disease. Int J Dev Biol 43: 463-468, 1999
27. Prieto M, Dipp S, Meleg-Smith S, El-Dahr SS: Ureteric bud derivatives express angiotensinogen and AT1 receptors. Physiol Genomics 6: 29-37, 2001
28. Norwood VF, Garmey M, Wolford J, Carey RM, Gomez RA: Novel expression and regulation of the renin-angiotensin system in metanephric organ culture. Am J Physiol Regul Integr Comp Physiol 279(2): R522-530, 2000
29. Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T, Ichikawa I: Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47: 140-147, 1995
30. Oshima K, Miyazaki Y, Brock JW 3rd, Adams MC, Ichikawa I, Pope JC 4th: Angiotensin type II receptor expression and ureteral budding. J Urol 166: 1848-1852, 2001
31. Miyazaki Y, Ichikawa I: Role of the angiotensin receptor in the development of the mammalian kidney and urinary tract. Comp Biochem Physiol A Mol Integr Physiol 128: 89-97, 2001
32. Norwood VF, Craig MR, Harris JM, Gomez RA: Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol Regul Integr Comp Physiol 272: R662-R668, 1997
33. Iosipiv IV, Schroeder M: A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol Renal Physiol 285: F199-F207, 2003
34. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K: Angiotensinogen-deficient mice with hypotension. J Biol Chem 269: 31334-31337, 1994
35. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 92: 2735-2739, 1995
36. Matsusaka T, Ichikawa I: Biological functions of angiotensin and its receptors. Annu Rev Physiol 59: 395-412, 1997
37. Niimura F, Labosky PA, Kakucchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan BM, Ichikawa L: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96: 2947-2954, 1995
38. Miyazaki Y, Tsuchida S, Nishimura H, Pope JC 4th, Harris RC, McKanna JM, Inagami T, Hogan BL, Fogo A, Ichikawa I: Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 102: 1489-1497, 1998
39. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377: 744-747, 1995
40. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750, 1995
41. Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA 3rd, Hogan BM, Fogo A, Brock JW 3rd, Inagami T, Ichikawa I: Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3: 1-10, 1999
42. Nishimura H, Tsuji H, Masuda H, Kasahara T, Yoshizumi M, Sugano T, Kimura S, Kawano H, Kunieda Y, Yano S, Nakagawa K, Kitamura H, Nakahara Y, Sawada S, Nakagawa M: The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost 82: 1516-1521, 1999
43. Favor J, Sandulache R, Neuhauser-Klaus A, Pretsch W, Chatterjee B, Senft E, Wurst W, Blanquet V, Grimes P, Sporle R, Schughart K: The mouse Pax2 (1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc Natl Acad Sci U S A 93: 13870-13875, 1996
44. Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H: Deregulation of Pax2 expression in transgenic mice generates severe kidney abnormalities. Nature 362: 65-67, 1993
45. Salomon R, Tellier AL, Attie-Bitach T, Amiel J, Vekemans M, Lyonnet S, Dureau P, Niaudet P, Gubler MC, Broyer M: PAX2 mutations in oligomeganephronia. Kidney Int 59: 457-462, 2001
46. Liu FY, Cogan MG: Angiotensin II: A potent regulator of acidification in the rat early proximal convoluted tubule. J Clin Invest 80: 272-275, 1987
47. Ingelfinger JR, Jung F, Diamond D, Haveran L, Lee E, Brem A, Tang S-S: Rat proximal tubular cell line transformed with origin-defective SV40 DNA: Autocrine Ang II feedback. Am J Physiol 276: F218-F227, 1999
48. Bharatula M, Hussain T, Lokhandwala MF: Angiotensin II AT1 receptor/signaling mechanisms in the biphasic effect of the peptide on proximal tubular Na+,K+-ATPase. Clin Exp Hypertens 20: 465-80, 1998
49. Iwai N, Yamano Y, Chaki S, Konishi F, Bardhan S, Tibbetts C, Sasaki K, Hasegawa M, Matsuda Y, Inagami T: Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun 177: 299-304, 1991
50. Makita N, Iwai N, Inagami T, Badr KF: Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commun 185: 142-146, 1992
51. Iwai N, Inagami T, Ohmichi N, Nakamura Y, Saeki Y, Kinoshita M: Differential regulation of rat AT sub 1a and AT sub 1b receptor mRNA. Biochem Biophys Res Commun 188: 298-303, 1992
52. Kitami Y, Okura T, Marumoto D, Wakamiya R, Hiwada K: Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 188: 446-452, 1992
53. Feliers D, Senthil D, Ghosh-Choudhury G, Barnes J, Kasinath BS: Selective translational regulation of vascular endothelial growth factor (VEGF) expression in proximal tubular cells (MCT) by angiotensin II (AII). J Am Soc Nephrol 14: 402A, 2003
54. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3: 1531-1540, 1992
55. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB: Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616, 2002
56. Booz GW, Day JN, Baker KM: Interplay between the cardiac rennin angiotensin system and JAK-STAT signalling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34: 1443-1453, 2002
57. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375: 247-250, 1995
58. Cai Y, Lechner MS, Nihalani D, Prindle MJ, Holzman LB, Dressler GR: Phosphorylation of Pax-2 by the c-Jun N-terminal kinase and enhanced Pax-2-dependent transcription activation. J Biol Chem 277: 1217-1222, 2002
59. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB: Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616, 2002
60. Aaronson DS, Horvath CM: A road map for those who don't know JAK STAT. Science 296: 1653-1655, 2002
61. Stayner C, Cunliffe HE, Ward TA, Eccles MR: Cloning and characterization of human Pax2 promoter. J Biol Chem 273: 25472-25479, 1998
62. Lechner MS, Levitan I, Dressler GR: PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin. Nucleic Acids Res 28: 2741-2751, 2000
63. Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J: The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 13: 447-453, 1996
64. Brophy PD, Ostrom L, Lang KM, Dressler G: R: Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 128: 4747-4756, 2001
65. Franch HA, Sooparb S, Du J, Brown NS: A mechanism regulating proteolysis of specific proteins during renal tubular cell growth. J Biol Chem 276: 19126-19131, 2001
66. Maeshima A, Maeshima K, Nojima Y, Kojima I: Involvement of Pax 2 in the action of activin A on tubular cell regeneration. J Am Soc Nephrol 13: 2850-2859, 2002
67. Liu S, Cieslinski DA, Funke AJ, Humes HD: Transforming growth factor-beta 1 regulates the expression of Pax 2, a developmental control gene, in renal tubule cells. Exp Nephrol 5: 2n95-300, 1997